Doxazosin Tablet
Product Images NDC 70771-1113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 70771-1113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container Label 2 mg- 100s Count (Ffdedf13 4b6d 489c 87e0 2e24385a6295 05)
This is a description of the medication, Doxazosin Tablets, USP. Each tablet contains 2mg of Doxazosin Mesylate, USP. Information on dosage and usage can be found in the accompanying prescribing information. The medication should be stored at a controlled room temperature and kept out of reach of children. These tablets are manufactured by Cadll Healthcare Ltd in Ahmedabad, India.*
Container Label 4 mg (100s count)
Container Label (8 mg)
Each tablet contains Doxazosin. This medication is available in the form of an SR tablet. Please store it at a temperature between 20 to 25°C, and avoid temperatures above or below this range. Keep the medication away from the reach of children. The medication comes in a tight container. The prescribing information is not readable due to errors. The manufacturer of this medication is Kz bl and the quantity of this medication is 100 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.